NEW YORK, Feb. 16, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Cardiovascular Systems, Inc. (“Cardiovascular Systems”) (NASDAQ:CSII) between September 12, 2011 and January 21, 2016.
You are hereby notified that a securities class action has been commenced in the USDC for the Central District of California. If you purchased or otherwise acquired Cardiovascular Systems securities between September 12, 2011 and January 21, 2016, your rights may be affected by this action. To get more information go to: http://zlk.9nl.com/cardiovascular-systems.
The complaint alleges that throughout the Class Period Defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Cardiovascular Systems distributed illegal kickbacks to health care providers; (2) Cardiovascular Systems engaged in the off-label promotion of its medical devices; and (3) Cardiovascular Systems violated FDA laws and regulations in connection with its medical devices. As a result of the foregoing, the Company’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in Cardiovascular Systems you have until April 12, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/cardiovascular-systems.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth
Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White
NTSB Investigates Boston Logan Airport Near-Miss Between Delta and American Airlines Jets
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom
Alphabet Stock Slides as AI Talent Exodus and SpaceX Losses Shake Investor Confidence
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post
Trump’s Quantum Push Lifts IBM Stock as CEO Arvind Krishna Receives White House Praise
Qualcomm Nears $4 Billion Acquisition of AI Chip Startup Modular
FedEx Stock Drops After Weak 2026 Earnings Forecast Despite Strong Q4 Results
California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 



